“IMPACT OF GLP-1 RECEPTOR AGONISTS ON LIVER ENZYMES AND FIBROSIS SCORES IN TYPE 2 DIABETIC AND NON-DIABETIC PATIENTS WITH FATTY LIVER DISEASE”. Frontier in Medical and Health Research 4, no. 3 (March 31, 2026): 4646–4654. Accessed November 8, 2026. https://fmhr.net/index.php/fmhr/article/view/3859.